What counts as a clinical trial failure?
This site focuses on trials that were terminated, suspended, or withdrawn. Not every stopped study failed scientifically, but these records often contain the clearest signals behind clinical trial failures.
Search clinical trial failures
Clinical Trial Failures is a searchable database of terminated, suspended, and withdrawn clinical trials. It is built to surface the strongest biological failure signals in registry text, especially weak efficacy, futility, safety issues, and other signs that an intervention did not work as intended.
Instead of reading thousands of trial records manually, you can review clinical trial failures by phase, sponsor, disease area, condition, intervention, geography, and stop reason.
The app is designed for biotech and pharma teams, investors, consultants, and researchers who want a faster way to study why clinical trials fail. The strongest use case is identifying whether a stopped study reflects a likely biological failure versus an operational, strategic, or funding decision.
Browse terminated, suspended, and withdrawn clinical trial records in one place.
Focus on likely efficacy, safety, operational, and other failure patterns.
Use the failure framing to distinguish scientific signals from administrative noise.
Start with the explorer, then move into summary pages to understand patterns behind clinical trial failures at both the portfolio and trial level.
These are the main questions people ask when they are researching clinical trial failures and the biological reasons trials stop.
This site focuses on trials that were terminated, suspended, or withdrawn. Not every stopped study failed scientifically, but these records often contain the clearest signals behind clinical trial failures.
Clinical trials can stop because of weak efficacy, futility, safety issues, operational problems, funding constraints, sponsor strategy changes, or regulatory factors. The app is most useful when you want to isolate probable biological failure from those other causes.
It is built for teams and researchers who want faster access to structured failed clinical trial intelligence, including operators, analysts, consultants, and investors.